These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7919346)

  • 1. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.
    Zipursky A; Wang H; Brown EJ; Squire J
    Blood; 1994 Oct; 84(7):2278-82. PubMed ID: 7919346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization.
    Kibbelaar RE; Mulder JW; Dreef EJ; van Kamp H; Fibbe WE; Wessels JW; Beverstock GC; Haak HL; Kluin PM
    Blood; 1993 Aug; 82(3):904-13. PubMed ID: 8338953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
    Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
    Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
    van Lom K; Hagemeijer A; Smit E; Hählen K; Groeneveld K; Löwenberg B
    Leukemia; 1995 Nov; 9(11):1818-21. PubMed ID: 7475268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization to assess aneuploidy for chromosomes 7 and 8 in hematologic disorders.
    Wyandt HE; Chinnappan D; Ioannidou S; Salama M; O'Hara C
    Cancer Genet Cytogenet; 1998 Apr; 102(2):114-24. PubMed ID: 9546063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase cytogenetic analysis of clonality in peripheral blood cells from a patient with Down syndrome and acute megakaryoblastic leukemia.
    Chang H; Li D; Nayar R; Ye C; Lau W; Sutherland DR
    Cancer Genet Cytogenet; 2004 Jan; 148(2):141-4. PubMed ID: 14734226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An abnormal clone with monosomy 7 and trisomy 21 in the bone marrow of a child with congenital agranulocytosis (Kostmann disease) treated with granulocyte colony-stimulating factor. Evolution towards myelodysplastic syndrome and acute basophilic leukemia.
    Shekhter-Levin S; Penchansky L; Wollman MR; Sherer ME; Wald N; Gollin SM
    Cancer Genet Cytogenet; 1995 Oct; 84(2):99-104. PubMed ID: 8536230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization.
    Gerritsen WR; Donohue J; Bauman J; Jhanwar SC; Kernan NA; Castro-Malaspina H; O'Reilly RJ; Bourhis JH
    Blood; 1992 Jul; 80(1):217-24. PubMed ID: 1611087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
    Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
    Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization.
    Nylund SJ; Verbeek W; Larramendy ML; Ruutu T; Heinonen K; Hallman H; Knuutila S
    Cancer Genet Cytogenet; 1993 Oct; 70(2):120-4. PubMed ID: 8242591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis in patients with myelodysplastic syndrome.
    Hu N; Bian M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood myelodysplastic syndrome.
    Chatterjee T; Choudhry VP
    Indian J Pediatr; 2013 Sep; 80(9):764-71. PubMed ID: 23912822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
    Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
    Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
    Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
    Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias.
    Zhao L; van Oort J; Cork A; Liang JC
    Am J Hematol; 1993 Jul; 43(3):205-11. PubMed ID: 8352237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.